Eiffel hires ex-PowderJect manager as COO
Wednesday, 15 October, 2003
Drug reengineering company Eiffel Technologies (ASX:EIF) has recruited former PowderJect technologies manager Dr Pascal Hickey as chief operating officer.
Hickey, who will be based at Eiffel's Sydney facilities, will be responsible for the company's R&D programs.
In a statement, Eiffel CEO Christine Cussen said Hickey's experience in pharmaceutical R&D would help the company further develop its technology. Hickey played a key role in the transition of PowderJect (now part of Chiron Corporation) from a small spin-off company from Oxford University to a mature and profitable company with 1500 employees, she said.
Common arthritis drug also lowers blood pressure
Scientists have known for a while that methotrexate helps with inflammation, but it may also help...
AI enables precise gene editing
A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
